enVVeno Medical Corp (NVNO)
5.13
0.00 (0.00%)
USD |
NASDAQ |
May 01, 16:00
5.13
0.00 (0.00%)
After-Hours: 20:00
enVVeno Medical Research and Development Expense (Quarterly): 2.981M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.981M |
| September 30, 2023 | 2.798M |
| June 30, 2023 | 4.214M |
| March 31, 2023 | 3.595M |
| December 31, 2022 | 2.797M |
| September 30, 2022 | 2.492M |
| June 30, 2022 | 3.073M |
| March 31, 2022 | 1.552M |
| December 31, 2021 | 1.782M |
| September 30, 2021 | 1.225M |
| June 30, 2021 | 1.09M |
| March 31, 2021 | 1.632M |
| December 31, 2020 | 2.277M |
| September 30, 2020 | 0.7582M |
| June 30, 2020 | 0.7062M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.5106M |
| December 31, 2019 | 0.7878M |
| September 30, 2019 | 0.677M |
| June 30, 2019 | 0.4283M |
| March 31, 2019 | 0.313M |
| December 31, 2018 | 0.2932M |
| September 30, 2018 | 0.4246M |
| June 30, 2018 | 0.2804M |
| March 31, 2018 | 0.2405M |
| December 31, 2017 | 0.3491M |
| September 30, 2017 | 0.0431M |
| June 30, 2017 | 0.1849M |
| March 31, 2017 | 0.0727M |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.4283M
Minimum
Jun 2019
4.214M
Maximum
Jun 2023
1.862M
Average
1.632M
Median
Mar 2021
Research and Development Expense (Quarterly) Benchmarks
| Align Technology Inc | 91.86M |
| ThermoGenesis Holdings Inc | 0.329M |
| NeuroOne Medical Technologies Corp | 1.483M |
| SINTX Technologies Inc | 1.824M |
| Nutriband Inc | 0.5515M |